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https://doi.org/10.1016/j.stemcr.2018.03.004SUMMARYChimeric mice have been generated by injecting pluripotent stem cells into morula-to-blastocyst stage mouse embryo or by introducing
moremature cells into later stage embryos that correspond to the differentiation stage of the donor cells. It has not been rigorously tested,
however, whether successful chimera formation requires the developmental stage of host embryo and donor cell to bematched. Here, we
compared the success of chimera formation following injection of primary neural crest cells (NCCs) into blastocysts or of embryonic stem
cells (ESCs) into E8.5 embryos (heterochronic injection) with that of injecting ESCs cells into the blastocyst or NCCs into the E8.5 em-
bryos (isochronic injection). Chimera formation was efficient when donor and host were matched, but no functional chimeric contri-
bution was found in heterochronic injections. This suggests that matching the developmental stage of donor cells with the host embryo
is crucial for functional engraftment of donor cells into the developing embryo.INTRODUCTION
Chimeric animals are typically generated fromcells ofmore
than one individual and can be produced by mixing of
early embryos (Gardner, 1968; Mintz, 1962; Tarkowski,
1961) or by engrafting cells or tissues into embryos at
different stages of development (Le Douarin and Teillet,
1973). In addition to being useful tools for the study of
development, the generation of interspecies human-ani-
mal chimeras has been proposed as a source of human cells
and organs for regenerative medicine (Masaki and Nakau-
chi, 2017; Wu et al., 2017). To define the parameters that
promote functional engraftment of donor cells into em-
bryos and chimera formation is important for the genera-
tion of interspecies chimera models.
The most common approach to generate chimeras
involves the injection of mouse embryonic stem cells
(mESCs) into morula-to-blastocyst stages (E2.5–3.5) of the
pre-implantation mouse embryo, producing postnatal
chimeric mice with donor cell contribution to all tissues
(Tam and Rossant, 2003). This method is routinely used
to produce gene-edited mice (Capecchi, 1989). The genera-
tion of chimeras at later stages of mouse development is
challenging, as the embryo is less accessible to manipula-
tion after implantation into the uterus (E4.5–5). An alterna-
tive approach is the introduction of test cells into ex vivo
cultured embryos, which enables the study of chimera
formation in vitro, but this approach does not allow obser-
vations beyond 2 days, the maximal time of embryo culti-
vation (Huang et al., 2012).
In conventional pre-implantation chimera generation,
the donor ESCs are developmentally matched (isochronic)
with the host blastocyst. However, it is not clear whetherThis is an open access article under the Cisochronic transplantation of donor cells is necessary for
successful engraftment. While a recent study reported
that somatic cells, such as primordial germ cells, failed to
contribute to chimera formation when heterochronically
introduced into blastocysts (Leitch et al., 2014), several
groups claimed that transplantation of various somatic
stem cell types such as neural precursors, mesenchymal
stem cells, or blood stem cells into the blastocyst in a heter-
ochronic injection, induced ‘transdifferentiaton’ and gave
rise to chimeras (Clarke et al., 2000; Geiger et al., 1998;
Jiang et al., 2002). However, the latter results have not
been reproduced under stringent criteria and remain
controversial.
We have shown that committed somatic stem cells,
when introduced isochronically into the host embryo,
generate chimeras efficiently: neural crest cells (NCCs)
introduced into the gastrulating embryo at E8.5 contribute
to neural-crest-derived lineages of the host such as pigment
cells and peripheral nervous system derivatives (Cohen
et al., 2016; Huszar et al., 1991; Jaenisch, 1985, and
M.A.C., unpublished data). In these experiments, neural
crest chimera formation was successful only when the
donor cells were microinjected in utero during a narrow
time window between E8.5 and E9.25, a time when the
endogenous NCCs leave the neural tube and migrate
through the embryo. This is consistent with the notion
that the developmental stage of the somatic donor cells
needs to be matched to that of the host embryo.
The goal of this study was, using ESCs and NCCs, to test
previous conclusions and to evaluate whether matching of
the developmental stage of donor cells and host embryo is
an important parameter for functional integration of the
cells and for chimera formation. For this, we used hostStem Cell Reports j Vol. 10 j 1–8 j May 8, 2018 j ª 2018 The Authors. 1
C BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Isochronic and Heterochronic Injection of mESCs or
Primary NCCs into the Mouse Embryo
(A) TdTomato-labeled mESCs were introduced into mouse blasto-
cysts. Embryos were tested for chimeric contribution using fluo-
rescence at E10.5 and by coat color in adult mice.
(B) mESCs injected into E8.5 host mouse embryos formed massive
teratoma outgrowths in postnatal mice (left). Histology of the
teratoma stained with H&E is presented (right).
(C) Mouse blastocysts injected with tdTomato-labeled primary
NCCs. Embryos were tested at E10.5 for chimeric contribution
using fluorescence. Negative and positive controls are presented
(right panel; wild-type [WT] and C57BL/6;R26(tdTomato) embryos,
respectively).
(D) FACS analysis of representative E10.5 embryos injected with
tdTomato-labeled mESCs and NCCs to blastocysts, along with con-
trol embryos, as indicated.
(E) Tomato positive and negative cells were sorted and analyzed for
the TdTomato gene by qPCR to determine chimeric contribution,
along with appropriate negative and positive controls, as indi-
cated. Overall, no cell contribution was found in embryos injected
with NCCs. For full statistical analysis of injected embryos, see
Table 1. Data are represented as means ± SD.
All scale bars represent 100 mm.
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post-implantation developmental stages, E3.5 and E8.5,
respectively, and compared the efficiency of chimera
formation by heterochronic and isochronic injection of
ESCs and NCCs. Our results argue that matching of devel-
opmental age of donor cells and host is critical for chimera
formation.RESULTS AND DISCUSSION
Isochronic and Heterochronic Injection of ESCs and
NCCs into Embryos
We used two developmentally distinct cell types as donor
cells: pluripotent mESCs, which were commonly used for
generating chimeras by combining with pre-implantation
embryos (E2.5–3.5), andNCCs, which are developmentally
restricted and were shown previously to functionally inte-
grate into E8.5 host embryos. NCCs were isolated from
C57BL/6;R26(tdTomato) donor mice with about 45% of the
cells being positive for HNK-1 and TFAP2a, two typical
NCC markers (Figure S1A). ESCs were isolated from the
same mouse strain. We injected tdTomato-labeled mESCs
orNCCs into blastocysts (E3.5) or E8.5 embryos to compare
embryo engraftment of developmentally matched (iso-
chronic) with that of non-matched (heterochronic) donor
cells.
While both cell types integrated into the inner cell mass
(ICM; E4.5) after injection into blastocysts, as expected,
only mESCs cells formed robust chimeras at E10.5 and
postnatal coat chimeras (Figures 1A and 1C; Table 1, top).
Table 1. Chimeric Contribution of Donor Cells after Injection into Pre- and Post-implantation Mouse Embryos
Cells
Host
Strain
No. of Blastocysts
Injected +
Transferred
Total No. of
Embryos
Dissected
No. of Chimeric
Embryos
% Chimeric
Embryos
Total No. of
Mice Born
No. of
Chimeric Mice
% Chimeric
Mice
Injections into Blastocysts
mESCs C57BL/6;R26(tdTomato/M2rtTA) A 96 36 20 55.5 NA NA NA
In vitro
differentiated
NCCs
C57BL/6;R26(tdTomato/M2rtTA) +
Teto::Bcl2 No Dox
A 70 22 0 0.0 22 0 0.0%
C57BL/6;R26(tdTomato/M2rtTA) +
Teto::Bcl2 + Dox
A 158 47 6 12.7 41 4 9.7%
Primary
NCCs
C57BL/6;R26(tdTomato) A 223 97 0 0.0% NA NA NA
C57BL/6;R26(tdTomato) W 53 NA NA NA 4 0 0.0%
C57BL/6;R26(tdTomato/M2rtTA) +
Teto::Bcl2 + Dox
A 185 15 0 0.0% 39 0 0.0%
Cells
Host
Strain
No. of Embryos
Injected (E8.5)
Total No. of
Mice Born
No. of Mice
with Teratoma
% Mice with
Teratoma
No. of
Chimeric Mice
% Chimeric
Mice
Injections into E8.5 Embryos
mESCs C57BL/6;R26(tdTomato/M2rtTA) or
C57BL/6;Col1a1(GFP)
W 72 29 12 41.3 0 0.0
Primary
NCCs
C57BL/6;Col1a1(GFP) W 33 27 0 0.0 9 33.3a
Top: Mouse blastocysts, injected with mESCs, in vitro differentiated NCCs, or primary NCCs, as indicated, were isolated at embryonic stages (E10.5–16.5) and fluorescence was used to measure chimeric
contribution. Alternatively, injected embryos were allowed to develop to term and coat color was used to assess chimeric contribution. The total number of injected blastocysts and the number of
chimeric embryos/mice are presented. Chimeric contribution was found when mESCs were injected isochronically into blastocysts. When mESCs were differentiated in vitro to NCCs and injected
into mouse blastocysts, only cells that overexpressed Bcl2 contributed to chimeras. However, chimeric contribution was found to be due to contaminating mESCs. No chimeric contribution was found
when primary NCCs were used as donor cells. Furthermore, even when primary NCCs overexpressing Bcl2 were used as donor cells, no chimeric contribution was detected. Bottom: Mice injected at E8.5
with either mESCs or NCCs were examined postnatally for coat color contribution. The total numbers of injected embryos, the numbers of chimeric mice as well as the number of mice with teratoma
outgrowth are presented. Teratoma formation rather than chimeric contribution was observed when mESCs were injected into E8.5 embryos.
A, albino CD1 mice; W, Wsh/Wsh white spotted mice.
aData summarized from Cohen et al. (2016).
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mation, Stem Cell Reports (2018), https://doi.org/10.1016/j.stemcr.2018.03.004Similarly, when NCCs were injected into the gastrulating
embryo at E8.5 (isochronic injection), robust coat color
contribution was found (Figures S1B and S1C; Table 1, bot-
tom). As shown previously, donor NCCs contributed to
pigmentation of postnatalmice (Cohen et al., 2016; Huszar
et al., 1991; Jaenisch, 1985) with coat color contribution
being significantly enhanced when the E8.5 host embryos
were mutant for the c-Kit gene (Wsh/Wsh), a mutation,
which causes death of melanoblasts thus providing a selec-
tive advantage (an ‘‘empty niche’’) for the donor NCCs.
In contrast, heterochronic injection of NCCs into blas-
tocysts, although integrated efficiently into the ICM (Fig-
ure 1C), failed to yield chimeras: none or only 0.03%
tdTomato positive cells were detected in E10.5 embryos
from NCC injected blastocysts (Figures 1C and 1D). Simi-
larly, when mESCs were introduced into E8.5 embryos
(heterochronic injection), the donor cells did not func-
tionally engraft to form chimeras but rather developed
massive teratoma outgrowths mainly in the backside of
the head (Figure 1B; Table 1, bottom), which is the site
where donor cells typically enter the embryo after E8.5 in-
jection (Cohen et al., 2016; Huszar et al., 1991; Jaenisch,
1985).
We assessed whether the few tdTomato+ cells seen in em-
bryos fromNCCs injected into blastocysts (Figure 1D) were
derived from the donor cells, rather than from auto-fluores-
cent dead cells. Genomic DNA was extracted from sorted
populations and qPCR was used to detect the presence of
tdTomato DNA (Figure 1E). Control C57BL/6;R26(tdTomato)
embryos, which are homozygous for the reporter gene,
demonstrated a high level of tdTomato DNA. TdTomato
DNA positive cells were found in embryos derived
from blastocysts injected with C57BL/6;R26(tdTomato/M2rtTA)
mESCs (heterozygous for the tdTomato) at a lower level
consistent with chimeric embryos consisting of het-
erozygous tdTomato cells. Importantly, the rare (0.03%)
tdTomato+ sorted cells of embryos derived from blastocysts
injected with NCCs were similar to negative controls and
showed no tdTomato amplification signal (Figure 1E).
These qPCR results confirm that NCCs injected at the blas-
tocyst stage cannot functionally engraft into post-implan-
tation embryos and that the rare tdTomato positive cells are
due to auto-fluorescence. Table 1 summarizes our experi-
ments of injecting mESCs or NCCs into blastocysts (top)
and the injections ofmESCs or primaryNCCs into E8.5 em-
bryos (bottom). The results indicate that matching the
developmental stage of donor and host, i.e., the injection
of ESCs into blastocysts and NCCs into E8.5 embryos,
leads to functional engraftment of mESCs and NCCs and
chimera formation. In contrast, when the developmental
stage of donor and host are notmatched (heterochronic in-
jection), no functional engraftment of the donor cells is
observed.4 Stem Cell Reports j Vol. 10 j 1–8 j May 8, 2018Inhibition of Apoptosis Does Not Promote
Heterochronic Chimera Formation
Recently, Nakauchi and colleagues reported that inhibition
of apoptosis by overexpression of Bcl2 can induce Sox17+
endoderm precursors cells to engraft into embryos after
heterochronic injection into the blastocyst: the Sox17+
were found to have colonized gut endoderm and yolk sac
of E9.5 embryos (Masaki et al., 2016). To test whether
anti-apoptotic activity would allow NCCs to functionally
contribute to blastocyst chimera formation, we generated
mESCs that conditionally overexpressed Bcl2. C57BL/6;
R26(tdTomato/M2rtTA) mESCs were infected with FUW-Teto:
Bcl2-T2A-PuroR lentivirus and clones carrying the trans-
gene were isolated by drug selection and differentiated
into NCCs. When injected into blastocysts, these cells
formed chimeras, as indicated by fluorescence in embryos
or coat color contribution in adult mice (Table 1 and Fig-
ure S2A). These results suggest that NCCs can functionally
integrate into the blastocyst. Alternatively, BCL2 expres-
sion may enhance survival and delay differentiation of
ESCs and enhance the maintenance of undifferentiated
cells as has been reported previously (Ardehali et al.,
2011; Yamane et al., 2005). Indeed, we found that the
in vitro derived NCCs cultures still contained a small frac-
tion (1.7% ± 0.24%) of contaminating pluripotent mESCs
as detected by pluripotent colony-forming assay. To test
whether chimera formation upon Bcl2 overexpressed was
due to contaminating pluripotent mESCs rather than
NCCs, we examined the chimeric contribution to a non-
NC-derived cell type. Peripheral blood cells (PBCs), isolated
from the chimeras and from their littermates were tested
for tdTomato fluorescence by fluorescence-activated cell
sorting (FACS). A significant fraction of PBCs from all
chimeras, but none of their littermates, were found to be
tdTomato positive (Figures S2B and S2C), indicating that
the donor cells in these chimeras were derived from the
pluripotent contaminating mESCs rather than from the
NCCs. These results suggest that BCL2 delays differentia-
tion of mESCs, leaving contaminating pluripotent cells in
culture, which contribute to chimera formation.
To stringently test the potential of BCL2-expressing
NCCs to generate chimeras upon injection into the blasto-
cyst, we prepared primaryNCCs overexpressing BCL2 from
E8.5 embryos. C57BL/6;R26(tdTomato/M2rtTA);Bcl2-T2A-PuroR
mESCs were injected into 4n blastocysts to form all-ESC
embryos or into 2n blastocysts to form chimeric embryos.
Primary tdTomato+ NCCs that conditionally overexpressed
Bcl2 were isolated from tetraploid explanted E8.5 mouse
embryos (Figures 2A and 2B) or from chimeric embryos
and selected for puromycin resistance (Figure 2C). To
induce Bcl2 expression, NCCs were cultured with Dox for
24 hr (Figure 2D). The C57BL/6;R26(tdTomato/M2rtTA);Bcl2-
T2A-PuroR primary NCCs were injected into albino mouse
Figure 2. Primary NCCs Overexpressing
Bcl2 Fail to Contribute to Blastocyst
Chimeras
(A) Schematic of the experiment: to
derived NCCs overexpressing Bcl2, C57BL/6;
R26(tdTomato/M2rtTA); FUW-Teto:Bcl2-T2A-
PuroR mESCs were injected into mouse 4n
fused blastocysts (right) or 2n blastocysts
(left). NCCs were derived from E8.5 neural
tube explants and selected as indicated.
To activate Bcl2 expression, NCCs were
treated with Dox 24 hr prior to injection.
NCCs were then injected into mouse blasto-
cysts, transplanted into foster mothers, and
tested for chimeric contribution.
(B) A representative all-ESC E8.5 embryo,
derived from prior injection of tdTomato-
labeled Teto:Bcl2-mESCs into a 4n-tetraploid
blastocyst. The whole embryo is derived
from the injected cell, and it is all tdTomato
positive. NCCs derived from this embryo
(no need for puromycin selection) were
then injected into blastocysts for secondary
chimera formation.
(C) A neural tube explant derived from a
chimeric E8.5 mouse embryo, which was
injected at the blastocyst stage with Teto:
Bcl2 tdTomato-labeled mESCs. Explanted
cells were treated with Dox and puromycin
for Bcl2 overexpression and drug selection
of the transgenic NCCs. Selected NCCs were
then injected into blastocysts. Scale bar
represents 100 mm.
(D) qPCR assay demonstrating Bcl2 over-
expression upon Dox treatment in NCCs
(n = 2).
(E) Blastocysts injected with tdTomato-
labeled primary NCCs overexpressing Bcl2
were analyzed at E10.5 for contribution of
donor cells by FACS. The percentages of
tdTomato positive cells of each embryo are
presented in red on the top. Tomato positive
and negative cells were analyzed by qPCR to determine chimeric contribution, along with appropriate negative and positive controls, as
indicated. Overall, even when BCL2 was overexpressed, no cell contributions were found in embryos injected with NCCs. For full statistical
analysis of injected embryos, see Table 1. Data are represented as means ± SD.
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mation, Stem Cell Reports (2018), https://doi.org/10.1016/j.stemcr.2018.03.004blastocysts to assess whether the Bcl2 anti-apoptotic activ-
ity supported chimera formation after heterochronic injec-
tion into the blastocyst. To maintain Bcl2 expression dur-
ing the relevant developmental stages, Dox was added to
the drinking water of foster mice until mid-gestation. As
shown in Table 1 and Figure 2E, we failed to detect donor
cell contribution to E10.5 embryos or to coat color in post-
natal mice. We conclude that matching the developmental
stage of NCdonor cells with the host embryo is essential for
neural crest chimera formation even when apoptosis is in-hibited by BCL2. Our data contrast with Sox17+ endoderm
donor cells expressing a Bcl2 transgene generating endo-
derm chimeras when injected into the blastocyst (Masaki
et al., 2016). The different results in our and the previous
study may be due to the different experimental designs
andmay reflect differences in how BCL2 affects cells differ-
entiated in vitro versus cells derived from the embryo. Alter-
natively, inhibition of apoptosis may allow functional
engraftment and chimera formation after heterochronic
injection in some but not other lineages.Stem Cell Reports j Vol. 10 j 1–8 j May 8, 2018 5
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mation, Stem Cell Reports (2018), https://doi.org/10.1016/j.stemcr.2018.03.004Human ESCs Do Not Functionally Integrate into the
Gastrulating Mouse Embryo
To test whether heterochronic injection of human ESCs
(hESCs) would contribute to chimera formation, we intro-
duced GFP-labeled hESCs into E8.5 mouse embryos. The
data summarized in Table S1 indicate that donor hESCs
did not functionally engraft into themouse host but rather
developed small clusters of outgrowths mainly in the back-
side of the head (Figure S3A). Moreover, when tdTomato-
labeled hESCs were co-injected along with GFP-labeled
human NCCs into E8.5 host mouse embryos, hESCs
formed clusters of cells, whereas human NCCs were found
migrating and contributing to host development, as previ-
ously reported (Cohen et al., 2016; Figure S3A). In some
cases, hESCs injected into E8.5 embryo were found
to form small teratoma outgrowths in postnatal mice
(Figure S3B).
Our results are consistent with previous observations
where mouse or human ESCs were injected into in vitro
cultured mouse embryos. Thus, epiblast stem cells
(EpiSCs), which correspond to the post-implantation stage
embryo, differentiated to cells of all germ layers when
grafted into cultured post-implantation mouse embryos.
In contrast, mESCs, which correspond to the pre-implanta-
tion stage embryo, failed to do so (Huang et al., 2012).
Similarly, hESCs, which are equivalent to mouse EpiSCs,
when grafted into cultured gastrula stage mouse embryos,
contributed to multiple tissue layers following 2 days of
in vitro culture (Mascetti and Pedersen, 2016; Wu et al.,
2015), supporting the notion that developmental match-
ing of donor cells and host is important for interspecies
cell engraftment. These observations are consistent with
the failure of conventional hESCs to form mouse-human
interspecies chimeras when injected into mouse blasto-
cysts (James et al., 2006). In efforts to adjust the develop-
mental stage of hPSCs, different protocols have been used
to convert conventional hESCs to a naive state that would
correspond to mESCs (Gafni et al., 2013; Takashima et al.,
2014; Theunissen et al., 2014, 2016), but chimera forma-
tion was inefficient. In contrast, a recent study used chem-
ical compounds to generate modified human PSCs; when
injected intomouse blastocysts, engraftment of the human
donor cells was observed in the mid-gestation host em-
bryos (Yang et al., 2017). Thus, the question whether cur-
rent naive human PSCs are chimera competent and are
developmentally equivalent to the mouse blastocyst re-
mains unresolved. Moreover, other parameters such as
the proliferation rate of the donor cells, or the evolutionary
distance between the host and injected cells serve as a bar-
rier for interspecies chimera formation (Cohen et al., 2016;
Masaki and Nakauchi, 2017; Wu et al., 2016).
Previous data suggest that stem cells transplanted into
more advanced embryos can functionally engraft. For6 Stem Cell Reports j Vol. 10 j 1–8 j May 8, 2018example, primordial germ cells, when introduced into sem-
iniferous tubules of postnatal mice differentiated to func-
tional spermatozoa (Chuma et al., 2005; Ohinata et al.,
2009). Similarly, injection of human embryonic glial cells
into the P0 mouse brain generated mature human astro-
cytes in the adult mouse brain (Windrem et al., 2014).
Our findings suggest that this might be restricted to some
stem cell populations but not to PSCs. While others re-
ported that injection of hESCs cells into the E14 mouse
brain generatedmature humanneurons in the adultmouse
brain (Muotri et al., 2005), we show thatmouse andhuman
PSCs develop teratomas rather than functionally contrib-
uting to chimeras when introduced into E8.5 mouse
embryos.
The data presented in this study are consistent with the
notion that matching the developmental stage of both
the donor and host embryo (isochronic injection) is an
important parameter for successful engraftment of ESCs
and NCCs into chimeric embryos (Figure 3). Donor cells
that were at a more mature or immature stage than the
host embryo were not able to contribute to chimera forma-
tion. It remains to be seen whether manipulation of the
donor cells such as interfering with apoptosis as shown in
endodermal donor cells (Masaki et al., 2016) could over-
come the inability of some developmentally mismatched
donor cell types to engraft.EXPERIMENTAL PROCEDURES
Mouse Lines and Husbandry
Mice were obtained from the Jackson Laboratory and maintained
in the Whitehead Institute animal facility. All experiments were
approved by the Committee on Animal Care at MIT, and animal
procedures were performed following the NIH guidelines.
Microinjection into Pre-implantation Embryos
Diploid embryos were obtained following standard superovulation
methods using pregnantmare serumand human chorionic gonad-
otropin (hCG). To obtain tetraploid (4n) blastocysts, electrofusion
was performed at 44–47hr post hCGusing a BEXLF-101 cell fusion
apparatus (Protech International). To generate chimeric embryos,
5–6 cells were injected into E3.5 blastocysts and about 6–20 in-
jected blastocysts were surgically transferred into 2.5 days post-
coitum pseudo-pregnant CD1 female mice following standard
procedures.
Microinjection into Mid-gestation Embryos
Microinjections were performed as previously described (Cohen
et al., 2016; Jaenisch, 1985). Laparotomy of E8.5 pregnant females
was performed by a long, vertical incision, and the uterus was
exposed. Cells were drawn into a glass micropipette and injected
into the distal third of the decidual swelling. Roughly, 2–5 3 103
cells (suspended in 0.25–0.75 mL of cell culture medium) were in-
jected per embryo.
E 3.5 E 8.5 BirthE 0.5
ES NCCs
Contribute to chimera
Do not contribute to chimera
Pre-implantation Post-implantation
+/- BCL2
Figure 3. Developmental Matching of Donor Cells with the Host
Embryo Is Essential for Proper Chimera Formation
The figure summarizes our results. Chimera formation was efficient
when the developmental stage of donor and host were matched. In
contrast, no chimeric contributions to the host were seen when
primary NCCs were injected into blastocysts, even when expression
of BCL2 was induced in the NCCs. Similarly, injection of PSCs into
gastrulating embryos did not generate chimeras but rather the
outgrowth of teratomas. Our data suggest that matching the
developmental stage of donor cells with the host embryo is an
important parameter for functional engraftment of the donor cells
for generating chimeras.
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Female mice were timed pregnant, and primary NCCs were iso-
lated from E8.5 embryos as previously described (Cohen et al.,
2016). Briefly, neural tubes from E8.5 embryos were cultured in tis-
sue culture dishes pre-coated with collagen (Thermo Fisher) in
DMEM/F12 medium (Thermo Fisher) containing 5% fetal bovine
serum (FBS; HyClone), 5% horse serum (ATCC), 1% penicillin/
streptomycin (Thermo Fisher), 1 mM L-glutamine (Thermo
Fisher), and 1% nonessential amino acids (Thermo Fisher). For
gene activation or cell selection, cells were cultured with Dox
(2 mg/mL) and puromycin (2 mg/mL; Sigma). The neural tubes
were removed after 2 days of culture, and at day 3, the migrating
NCCs were dissociated and harvested using Accutase (Thermo
Fisher) prior to microinjection.
Immunostaining
Cells were fixed in 4% paraformaldehyde in PBS and immuno-
stained according to standard protocols. Cells were mounted
with Fluoro-mount G (Electron Microscopy Sciences) and imaged
using a Zeiss LSM 710 laser scanning confocal microscope. Mouse
tissues were dissected and fixed in 10% formalin overnight. Tissues
were embedded in paraffin, sectioned, and stained for H&E.
Assessment of Cell Contribution to Chimeras
Embryos were harvested between E10.5 to E16.5 of gestation, and
the cell contribution to the embryos were determined by thepresence of a fluorescent protein signal. Embryos were imaged us-
ing a Nikon SMZ18 stereomicroscope. For further analysis, whole
embryos were dissociated using Papain (Worthington Biochem)
and sorted using Sony SH800S Cell Sorter.qPCR
For the cell contribution in chimeric embryos, genomic DNA was
extracted from sorted cells. All DNA samples were run in technical
triplicates using Fast SYBR Green Master Mix (Thermo Fisher) in
the QuantStudio 6 Flex Real-Time PCR System (Thermo Fisher).
Relative quantification was determined by the changes in steady-
state donor cells (tdTomato) acrossmultiple samples and its relative
level to DNA internal control (UCNE TFAP2A#463). For Bcl2 expres-
sion, total RNA was isolated (RNeasy Kit, QIAGEN) and reverse
transcribed (Superscript III First Strand Synthesis kit, Invitrogen).
qRT-PCR analysis was performed in triplicate. Gene expression
was normalized to GAPDH expression. Error bars represent the
SD of triplicate reactions.
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